Axsome Therapeutics (AXSM) Capital Expenditures (2015 - 2026)
Axsome Therapeutics' Capital Expenditures was $450,000 in Q2 2026, compared with $13,000 a year earlier and up 271.9% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Capital Expenditures (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Axsome Therapeutics' Capital Expenditures was $700,000 through Jun 30, 2026, up 48.6% year-over-year; for FY2025, it came in at $480,000, up 77.8% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 59.9% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $270,000 in FY2024 (-53.6%), $582,000 in FY2023 (-17.1%), $702,000 in FY2022 (+127.9%) and $308,000 in FY2021 (+571.2%).
- The Q2 2026 figure marks the highest quarterly Capital Expenditures in data going back to Q1 2015.
- Compared with a year earlier, Capital Expenditures was higher in three of the last seven quarters, with growth averaging 65.7%.
- The best year-over-year quarter for Capital Expenditures over five years was Q1 2022 (growth of 613.5%); the worst was Q4 2021 (a decline of 97.8%).
- Per Business Quant data, AXSM's Capital Expenditures in the three quarters before Q2 2026 was $121,000 (Q1 2026), $71,000 (Q4 2025) and $58,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Axsome Therapeutics | 9.64 Bn | 8.37 Bn | 204.81 Mn | 450,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 450,000.00 |
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 71,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 338,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 371,000.00 |
| Jun 30, 2023 | 133,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Sep 30, 2022 | 66,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | 214,000.00 |
| Dec 31, 2021 | 451.00 |
| Sep 30, 2021 | 258,677.00 |
API Access
Axsome Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();